RI

Rajiv Indravadan Modi

Active Director Managing Director DIN 01394558
DIN 01394558 First appointment Mar 1990 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 12 active board seats
Past companies 17 historical roles
Total affiliations 29 Since Mar 1990
Shareholding value •••• Premium profile

About Rajiv Indravadan Modi

Data last updated:

Rajiv Indravadan Modi is a Managing Director at Cadila Pharmaceuticals Limited (since 1991), Director at Irm Energy Limited (since 2015) and Director at Apollo Hospitals International Limited (since 2006), and holds 9 more current directorships. The companies operate in Pharma, Oil & Gas and Healthcare. The 11 current companies with reported revenue have a combined latest revenue of ₹5,694 Cr; the largest is Cadila Pharmaceuticals Limited at ₹3,869 Cr (FY 2025). Earlier, Rajiv Indravadan Modi was a Director at Phd Chamber Of Commerce And Industry (2022–2024) and Director at Cadila Laboratories Private Limited (1991–2024) and 15 more.

DIN 01394558
Primary Designation Managing Director
Industry Pharma
First Appointment 26 Mar 1990
Oldest Company Age 45 yrs
Largest company Cadila Pharmaceuticals Limited · ₹3,869 Cr (FY 2025)
Combined revenue ₹5,694 Cr across 11 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Cadila Pharmaceuticals Limited U24231GJ1991PLC015132
Managing Director28 Feb 19911991₹3,869 Cr (FY 2025)Active
Irm Energy Limited L40100GJ2015PLC085213
Director01 Dec 20152015₹980 Cr (FY 2024)Active
Director31 Jul 20061997₹341 Cr (FY 2025)Active
Irm Private Limited U74120GJ1994PTC023239
Director11 Oct 19941994₹307 Cr (FY 2025)Active
Irm Enterprises Private Limited U74110GJ2009PTC058116
Director04 Aug 20112009₹152 Cr (FY 2025)Active
Apollo Cvhf Limited U74140GJ2016PLC086449
Director15 Mar 20162016₹34.40 Cr (FY 2025)Active
Cpl Biologicals Private Limited U01403GJ2009PTC056409
Director24 Mar 20092009₹8.01 Cr (FY 2025)Active
Nominee Director22 Aug 20192019₹1.57 Cr (FY 2025)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Phd Chamber Of Commerce And Industry U74899DL1951NPL001947
Director20 Jul 20221951₹63.29 Cr (FY 2025)Active
Cadila Laboratories Private Limited U24231GJ1973PLC002286
Director05 Oct 19911973₹6.01 Cr (FY 2025)Active
Director13 Jun 20082008₹15.53 Cr (FY 2023)Active
Cpl Holdings Private Limited U74110GJ2009PTC056511
Director01 Apr 20092009₹16,816 (FY 2017)Converted To Llp
Inverika Bioresearch Private Limited U73100GJ2012PTC070636
Director07 Jun 20122012₹20.1 Lakh (FY 2025)Active
Director01 Oct 20141973₹4,475 Cr (FY 2026)Active
Casil Industries Limited U24230GJ2012PLC071212
Director19 Jul 20122012Amalgamated
Director28 Feb 20122012Strike Off
Casil Industries Limited U24231GJ2000PLC038320
Director07 Jul 20002000Amalgamated
Director26 Mar 19901981₹6.2 Lakh (FY 2020)Amalgamated
Medtek Asia Private Limited U33111GJ1994PTC050484
Director24 Mar 19991994Amalgamated
Director17 Oct 19951995₹1.54 Cr (FY 2020)Amalgamated
Cpl Infrastructure Private Limited U67120GJ1995PTC025713
Director03 May 19951995Amalgamated
Casil Finance Private Limited U67120GJ1997PTC032109
Director15 Apr 19971997Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Board colleagues of Rajiv Indravadan Modi

NameDINCompanyDesignation
Girdhar Prem Balwani00328949Cadila Pharmaceuticals LimitedDirector
Kamlesh Navaratnalal ShahCadila Pharmaceuticals LimitedCfo
Parul Nikunj Shah09314433Cadila Pharmaceuticals Limited , Irm Enterprises Private LimitedAdditional Director
Rajiv Rajiv Modi10276899Cadila Pharmaceuticals Limited , Irm Energy Limited and 6 moreDirector
Ramesh Ratilal Choksi06636737Cadila Pharmaceuticals Limited , Apollo Hospitals International Limited and 7 moreWhole-Time Director
Renuka Anjanikumar UpadhyayCadila Pharmaceuticals LimitedCompany Secretary
Subir Kumar Das02237356Cadila Pharmaceuticals Limited , Irm Enterprises Private LimitedAdditional Director
Abhay Arvind Gupte02145565Irm Energy LimitedDirector
Akshit Nandkishor SoniIrm Energy LimitedCompany Secretary
Amit Lalitkumar Doshi01603380Irm Energy LimitedDirector
Amitabha Banerjee05152456Irm Energy Limited , Apollo Hospitals International Limited and 7 moreWhole-Time Director
Ashish MaheshwariIrm Energy LimitedCfo
Badri Narayan Mahapatra02479848Irm Energy LimitedDirector
Dharamchand Harakchand Jain02425815Irm Energy Limited , Irm Private LimitedDirector
Krishan Kumar Gupta03476812Irm Energy LimitedDirector
Manoj Kumar SharmaIrm Energy LimitedCeo
Preetha Reddy00001871Irm Energy Limited , Apollo Hospitals International Limited and 1 moreDirector
Vivek Vishwas Wathodkar08486382Irm Energy LimitedDirector
Akhileswaran Krishnan05299539Apollo Hospitals International Limited , Apollo Cvhf LimitedDirector
Ganesan Venkatraman00010063Apollo Hospitals International LimitedDirector
Jelson A KavalakkatApollo Hospitals International LimitedCeo
Madhu Sasidhar10667982Apollo Hospitals International LimitedDirector
Mitul Maeshkumar Dave09698848Apollo Hospitals International LimitedDirector
Pratap Chandra Reddy00003654Apollo Hospitals International LimitedDirector
Sudhir Kumar SahuApollo Hospitals International Limited , Apollo Cvhf LimitedCfo

Directorship timeline

Open interactive timeline →
Cpl Biologicals Private Limited
La Vie Biologicals Private Limited
Casil Industries Limited
Casil Bg Medical Devices Private Limited
Premium access

Shareholding and investment profile for Rajiv Indravadan Modi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rajiv Indravadan Modi

Rajiv Indravadan Modi currently holds 12 directorships: Cadila Pharmaceuticals Limited (Managing Director, since 28 Feb 1991, revenue ₹3,869 Cr (FY 2025)); Irm Energy Limited (Director, since 01 Dec 2015, revenue ₹980 Cr (FY 2024)); Apollo Hospitals International Limited (Director, since 31 Jul 2006, revenue ₹341 Cr (FY 2025)); Irm Private Limited (Director, since 11 Oct 1994, revenue ₹307 Cr (FY 2025)); Irm Enterprises Private Limited (Director, since 04 Aug 2011, revenue ₹152 Cr (FY 2025)); and 7 more.

Rajiv Indravadan Modi was first appointed on 26 Mar 1990 as Director at Karnavati Engineering Private Limited. The most recent appointment on record is 20 Jul 2022 at Phd Chamber Of Commerce And Industry.

The 11 current companies of Rajiv Indravadan Modi that report revenue have a combined latest revenue of ₹5,694 Cr: Cadila Pharmaceuticals Limited ₹3,869 Cr (FY 2025); Irm Energy Limited ₹980 Cr (FY 2024); Apollo Hospitals International Limited ₹341 Cr (FY 2025); Irm Private Limited ₹307 Cr (FY 2025); Irm Enterprises Private Limited ₹152 Cr (FY 2025); and 6 more.

Rajiv Indravadan Modi held 17 earlier board appointments: Phd Chamber Of Commerce And Industry (Director, 20 Jul 2022 to 27 May 2024); Cadila Laboratories Private Limited (Director, 05 Oct 1991 to 08 Mar 2024); Stemcyte India Therapeutics Private Limited (Director, 13 Jun 2008 to 22 Feb 2022); Cpl Holdings Private Limited (Director, 01 Apr 2009 to 03 Dec 2017); Inverika Bioresearch Private Limited (Director, 07 Jun 2012 to 16 Mar 2022); and 12 more.

The current boards of Rajiv Indravadan Modi's companies include Girdhar Prem Balwani (Cadila Pharmaceuticals Limited), Kamlesh Navaratnalal Shah (Cadila Pharmaceuticals Limited), Parul Nikunj Shah (Cadila Pharmaceuticals Limited), Rajiv Rajiv Modi (Cadila Pharmaceuticals Limited), Ramesh Ratilal Choksi (Cadila Pharmaceuticals Limited), Renuka Anjanikumar Upadhyay (Cadila Pharmaceuticals Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available